A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.

about

A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.

Item

http://www.wikidata.org/entity/Q42235236

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.

@en

A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.

@nl

type

Item

label

A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.

@en

A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.

@nl

prefLabel

A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.

@en

A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.

@nl

P1476

A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.

@en

P2093

Ari Chaouat

http://www.w3.org/2001/XMLSchema#string

Damien Mandry

http://www.w3.org/2001/XMLSchema#string

Emmanuel Gomez

http://www.w3.org/2001/XMLSchema#string

François Chabot

http://www.w3.org/2001/XMLSchema#string

Matthieu Canuet

http://www.w3.org/2001/XMLSchema#string

Morgane Faure

http://www.w3.org/2001/XMLSchema#string

Romain Kessler

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiopulmonary function in patients with pulmonary hypertension.

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice

Reactive Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-Occlusive Disease in a Patient with Repaired Scimitar Syndrome.

Pulmonary hypertension in COPD.

Pulmonary veno-occlusive disease: a case series and new observations.

Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.

Pulmonary hypertension in COPD: results from the ASPIRE registry.

Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.

P304

74-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1016/J.RMCR.2017.04.001

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter Dorfmuller

P577

2017-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28413774

http://www.w3.org/2001/XMLSchema#string

P932

5384413

http://www.w3.org/2001/XMLSchema#string